AMR.Solutions newsletter, website, and connected social media
Wellcome Trust
Rex Life Sciences LLC
Since 2015, Dr. John H. Rex has worked to develop a digital communication platform for the antimicrobial resistance (AMR) R&D community both promotes innovative R&D and energizes policy changes to address the intertwined issues of access, stewardship, and innovation. The platform consists of a free newsletter, copies of each newsletter posted on http://amr.solutions and LinkedIn, tweets regarding newsletters, and a YouTube channel providing content related to the newsletters. As of this writing (May 2022), AMR.Solutions has 2,600+ subscribers from 50+ countries around the globe with an average of 2,500 opens and 800 clicks per newsletter. These subscribers are all heavily involved with AMR-focused projects and the newsletter is viewed as a must-read by many in the community. From a recent survey: “It provides information as well as analysis which are crucial to our thinking when tackling AMR. I am delighted that it has a wide range of topics covered from basic R&D to public health and policy.” A grant from Wellcome Trust for Sep 2020 to March 2022 provided transformative supportive for the project. This grant application proposes that Wellcome Trust again support the further transformation and growth of this project via website maintenance, audience growth, and digital presence.
No Research Activity assigned